Differential analgesic effect of tenoxicam on post-cesarean uterine cramping pain between primiparous and multiparous women.

BACKGROUND AND PURPOSE: Uterine cramping pain is related to prostaglandins, which are mediated by cyclooxygenase. However, it is unknown whether the analgesic effects of the non-selective cyclooxygenase inhibitor tenoxicam are different between primiparous and multiparous women. This placebo-controlled, double-blind study compared the analgesic effect of tenoxicam on post-cesarean uterine cramping pain in primiparous and multiparous women. METHODS: Forty primiparous women and 40 multiparous women who were scheduled for elective cesarean delivery were allocated into the following 4 groups: saline-primipara (SP) group, tenoxicam-primipara (TP) group, saline-multipara (SM) group, and tenoxicam-multipara (TM) group. Saline or 20 mg tenoxicam was intravenously injected immediately after clamping of the umbilical cord. All patients received patient-controlled analgesia for postoperative pain control. Resting wound pain, uterine cramping pain, morphine consumption, and morphine-related side effects were evaluated at 4 and 24 hours after surgery. RESULTS: At 24 hours after surgery, tenoxicam-related relief of uterine cramping pain was 2.1 in primiparous women (visual analog scale: SP 5.6 (4.4-6.8) minus TP 3.5 (2.2-4.9); p < 0.01). The tenoxicam-related morphine-sparing effect was 14 mg (45%) in primiparous women (SP 31.4 mg (23.9-38.8) minus TP 17.4 mg (11.6-23.2); p < 0.01). The tenoxicam-related relief of uterine cramping pain and tenoxicam-related morphine-sparing effect were not significant in multiparous women. CONCLUSIONS: This study revealed that the analgesic effect of tenoxicam on post-cesarean uterine cramping pain is greater in primiparous women than in multiparous women. Further studies are required to determine whether a higher dosage of tenoxicam is beneficial to reduce uterine cramping pain in multiparous women.     

猪门静脉回流阻断模型内毒素的移位

【目的】拟在猪的肠血管阻断模型中探讨门静脉回流阻断肠淤血可能造成的内毒素移位和肿瘤坏死因子释放。【方法】采用种群相近体质量22～25kg雌性小猪8只，无感染症状。分离门静脉和肝后下腔静脉分别阻断、然后开放各60min．观察血压、心率，阻断前和开放60min各取回肠末端小肠全层行光镜、电镜检查，测定门、颈静脉血内毒素及肿瘤坏死因子（TNF—α）含量。【结果】门静脉和肝后下腔静脉阻断后，肠淤血、水肿，并随时间延长而加重，光镜检查表明实验后肠粘膜和腺体明显损伤，电镜检查表明细胞超微结构轻微异常。阻断前后的血内毒素、TNF—α含量无显著性差异。【结论】①肠静脉回流阻断60min引起的肠道淤血可导致肠粘膜屏障损伤。②在60min内肠淤血性的损伤不会引起肠腔内内毒素的大量移位及TNF—α的释放。     

粒细胞集落刺激因子治疗大鼠局灶性脑缺血再灌注损伤

OBJECTIVE: To study the therapeutic effects of granulocyte colony-stimulating factor (G-CSF) on focal cerebral ischemia-reperfusion injury in rats. METHODS: Adult male SD rats were subjected to transient (2 h) middle cerebral artery occlusion (MCAO) and scored 48 h later for such neurological functions as spontaneous movement, paresis, forelimb motor function, climbing ability, pain sensation, and position sense. Twenty rats with the total score less than 12 were divided equally into two groups to receive daily subcutaneous injection of 20 microg/kg of G-CSF for 19 days or the same dose of saline injection (control group). The rats in the two groups were also given intraperitoneal injection of Brdu10 mg/kg for 19 days. The neurological functions of the rats in both groups were examined on a weekly basis after MCAO and on day 21, the rats were killed to prepare frozen sections of the brain tissues for double immunohistochemical staining with Brdu and glial fibrillary acidic protein antibody to identify the neural cells newly evolved from the stem cells. RESULTS: The rats in G-CSF group showed better neurological function recovery than the control rats 3 weeks after MCAO (P<0.05). Obvious regeneration of the neural cells was observed around the infarction area in the rats receiving G-CSF treatment. CONCLUSION: G-CSF promotes neurological function recovery and neural cell regeneration after cerebral infarction in rats and can be effective for intervention of focal cerebral ischemia-reperfusion injury.     

胸部X线与CT诊断支气管结核的临床价值

目的分析胸部X线及CT影像征象在支气管结核临床诊断中的价值和意义。方法收集本院经病理及电子支气管镜证实为支气管结核105例，对照其胸部X线与CT表现进行回顾性分析。结果105例患者中，胸部X线显示伴有肺内结核灶77例，气管狭窄、肺叶不张分别为51例和49例，未见异常表现17例。胸部CT扫描对气管狭窄及肺叶不张检出率明显提高，分别为72例和61例，且能观察到气管内壁情况及狭窄或阻塞后肺野情况，伴肺内结核灶79例，无异常改变只有8例。结论提高对支气管结核的影像学认识，能有效地提高临床诊断准确率。     

中西药联合胆肾推经仪治疗肝内胆管结石38例临床观察

目的 观察胆维他、25％硫酸镁、中药消炎利胆Ⅰ号联合胆肾推经仪治疗肝内胆管结石的临床疗效。方法 38例肝内胆管结石患者口服消炎利胆Ⅰ号溶石化石，胆维他利胆消炎保肝，25％硫酸镁解痉止痛扩张肝胆管。配合胆肾推经平板式电极刺激和手柄式电极推按，确定排石体位、结石部位，调节仪器频率和强度，疗程为10天和30天。结果 治疗后，经B超、胆囊造影、CT检查对比，排石总有效率91．61％。其中排净27例（占71．05％），显效8例（占20．56％），无效3例（占7．9％），与治疗前相比，差异有显著性（P〈0．1〉。结论 中西药联合胆肾推经仪治疗肝内胆管结石可明显提高排石率，改善胆道炎症，消除黄疸，是一种安全有效，经济方便的治疗方法。     

伊柔美白霜对家兔皮肤祛斑效果的观察

目的考察伊柔美白霜的祛斑功效。方法在家兔皮肤上涂抹补骨脂酊，待日光照射使皮肤上形成黄褐斑后，涂抹伊柔美白霜。结果涂抹伊柔美白霜20d后，黄褐斑有明显减退。结论伊柔美白霜具有脱色、增白的功效。     

The use of microimplants in orthodontic anchorage.

PURPOSE: Various types of temporary implants have been introduced to serve as orthodontic anchorage. The hypothesis of this study is that microimplants of 1.2 mm diameter can be used as orthodontic anchors, and that their success is related to their length. The aim of this study is to determine the incidence of anchor retention after orthodontic force application for moving teeth, and to determine the relationship of microimplant length to retention rate. METHODS: Fifty-nine microimplants (diameter: 1.2 mm) were placed in 29 patients as orthodontic anchorages. After 2 weeks of microimplant placement, a force of 100 to 200 g was loaded with an elastometric chain or NiTi coil spring. Risk factors were characterized as to why a microimplant may fail, and Fisher's exact test was used for statistical analysis. RESULTS: Nine microimplants were removed and the overall success rate was 84.7%. Exploring the causes for failure, we found significant differences between the length of microimplants and success rate; 6 mm was 72.2% and 8 mm was 90.2%. CONCLUSIONS: The results suggest that microimplants are suited as an alternative orthodontic anchorage. We recommend that 8-mm microimplants are preferable to 6-mm.     

急性等容性血液稀释对血浆ET和CGRP水平的影响

目的　探讨急性等容性血液稀释 (ANH)对血浆内皮素 (ET)和降钙基因相关肽(CGRP)水平的影响。方法　选择非心脏手术ASAⅠ～Ⅱ级患者 2 0例 ,麻醉前快速输入复方乳酸钠1 0～ 1 5ml/kg。麻醉后从桡动脉放血 1 0ml/kg ,同时经静脉输入等量的 4 %琥珀酰明胶。观察ANH麻醉前 (T0 )、血液稀释完成后 1 0min(T1 )、2 0min(T2 )、30min(T3 )的血液动力学、血浆ET和CGRP浓度的变化。结果　ANH前后MAP、HR、SpO2 和ECG均较稳定。ANH后 1 0min、2 0min血浆ET水平分别为 (1 4 4 4 7± 1 9 1 7) pg/ml和 (1 5 7 1 7± 1 2 4 5 ) pg/ml,但明显高于ANH前的 (1 2 7 6 8±2 0 92 ) pg/ml(P <0 0 5 )。ANH后 1 0min、2 0min血浆CGRP水平分别为 (5 4 72± 2 5 6 5 )pg/ml和(5 5 32± 1 7 94 )pg/ml,也明显高于ANH前的 (4 4 6 2± 1 6 90 ) pg/ml(P <0 0 5 )。而ET/CGRP比值无明显变化。结论　ANH近期血浆ET和CGRP水平均有一定的增加 ,但ET/CGRP比值的变化无统计学意义 ,同时心血管反应不明显 ,表明血浆ET和CGRP的动态平衡对ANH时的循环稳定起着重要的作用     

Studies on the behavior of photodegradation of poly(cyclohexylmethylsilane)

The fluorescence spectra of poly(cyclohexylmethylsilaane) (PCHMS) solutions or films before and after ultraviolet irradiation in air were studied. The experimental results showed that the positions of the fluoresence peaks shift to shorter wavelength and the fluorescence intensities decrease gradually with increasing UV irradiation time. The results of UV spectra, GPC and ESCA, and IR spectra of PCHMS solutions or films upon UV exposure in air indicate that these phenomena are in accordance with a combined process of photodegradation and photooxidation, which lead to a decrease of the molecular weights and formation of siloxane structures in the polysilane main chains.     

重组合异种骨临床疗效观察

重组合异种骨（ＲＨＢ）骨形成蛋白（ＢＭＤ）与去除抗原特性后的异种松质骨的复合物，是近年来医学研究的一个新成果。既具有ＢＭＰ的高度诱导成骨作用，又具有松质骨的支架作用，十分便于临床使用、填充骨缺损。作者等应用ＲＨＢ治疗１６例骨缺损及骨不连，证实它是一种高效的成骨诱导物质，诱导生骨作用肯定，无明显副作用，临床使用方便，较自体骨移植愈合时间快，避免了取自体髂骨的痛苦。作者等认为，本生物制品颇值得大力推广应用。